Digestive And Liver Disease

Digestive And Liver Disease

消化和肝病

  • 3区 中科院分区
  • Q1 JCR分区

期刊简介

《Digestive And Liver Disease》是由Elsevier出版社于2000年创办的英文国际期刊(ISSN: 1590-8658,E-ISSN: 1878-3562),该期刊长期致力于胃肠肝病学领域的创新研究,主要研究方向为医学-胃肠肝病学。作为SCIE收录期刊(JCR分区 Q1,中科院 3区),本刊采用OA未开放获取模式(OA占比0.0354...%),以发表胃肠肝病学领域等方向的原创性研究为核心(研究类文章占比87.68%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在203篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Digestive And Liver Disease审稿周期约为 一般,3-8周 约6.5周。该刊近年未被列入国际预警名单,年发文量约203篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 203 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 33 / 143

77.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 35 / 143

75.87%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.1 SJR:0.873 SNIP:0.832
学科类别 分区 排名 百分位
大类:Medicine 小类:Gastroenterology Q1 40 / 167

76%

大类:Medicine 小类:Hepatology Q2 28 / 82

66%

期刊发文

  • p53 upregulated by HIF-1 alpha promotes gastric mucosal epithelial cells apoptosis in portal hypertensive gastropathy

    Author: Zhang, Yafei; Lu, Hongwei; Ji, Hong; Li, Yiming

    Journal: DIGESTIVE AND LIVER DISEASE. 2023; Vol. 55, Issue 1, pp. 81-92. DOI: 10.1016/j.dld.2022.06.016

  • Association between multiple gene promoter hypermethylation and the risk of gastric cancer: A systematic review and meta-analysis

    Author: Wen, JianRu; Deng, SiXiu; Bi, YuHua; Qiao, LiJuan; Xu, Hui

    Journal: DIGESTIVE AND LIVER DISEASE. 2023; Vol. 55, Issue 1, pp. 40-45. DOI: 10.1016/j.dld.2022.03.009

  • HOTAIR modulates hepatocellular carcinoma progression by activating FUT8/core-fucosylated Hsp90/MUC1/STAT3 feedback loop via JAK1/STAT3 cascade

    Author: Guo, Yanru; Liu, Bing; Huang, Tong; Qi, Xia; Li, Shijun

    Journal: DIGESTIVE AND LIVER DISEASE. 2023; Vol. 55, Issue 1, pp. 113-122. DOI: 10.1016/j.dld.2022.04.009

  • Critical signaling pathways governing colitis-associated colorectal cancer: Signaling, therapeutic implications, and challenges

    Author: Xin, Jiang

    Journal: DIGESTIVE AND LIVER DISEASE. 2023; Vol. 55, Issue 2, pp. 169-177. DOI: 10.1016/j.dld.2022.08.012

  • Sensitivity to thyroid hormones is associated with advanced fibrosis in euthyroid patients with non-alcoholic fatty liver disease: A cross-sectional study

    Author: Li, Ruifang; Zhou, Li; Chen, Chen; Han, Xu; Gao, Min; Cheng, Xiaojing; Li, Jia

    Journal: DIGESTIVE AND LIVER DISEASE. 2023; Vol. 55, Issue 2, pp. 254-261. DOI: 10.1016/j.dld.2022.06.021

  • Detection of potential pathogen in pancreatic fluid aspiration with metagenomic next-generation sequencing in patients with suspected infected pancreatic necrosis

    Author: Hong, Donghuang; Wang, Peng; Chen, Yingjie; Zhang, Jingzhu; Jiang, Wendi; Ye, Bo; Li, Gang; Zhou, Jing; Mao, Wenjian; Tong, Zhihui; Li, Weiqin; Ke, Lu

    Journal: DIGESTIVE AND LIVER DISEASE. 2023; Vol. 55, Issue 2, pp. 243-248. DOI: 10.1016/j.dld.2022.07.014

  • Treatment of refractory hepatic encephalopathy induced by spontaneous portosystemic shunt: Selective splenic vein embolization versus shunt embolization

    Author: Zhang, Linhao; Wei, Bo; Wang, Zhidong; Tong, Huan; Wu, Hao

    Journal: DIGESTIVE AND LIVER DISEASE. 2023; Vol. 55, Issue 3, pp. 381-386. DOI: 10.1016/j.dld.2022.08.041

  • Knockdown of FGFR3 inhibits the proliferation, migration and invasion of intrahepatic cholangiocarcinoma

    Author: Chen, Yi-hui; Yang, Shao-hua; Liu, Li-xin; Hu, Sheng; Wang, Xue-jun; Liao, Zhou-jun; Huan, Yun-feng; He, Kai; Zhang, Xiao-wen

    Journal: DIGESTIVE AND LIVER DISEASE. 2023; Vol. 55, Issue 3, pp. 400-406. DOI: 10.1016/j.dld.2022.07.017